Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study.
Charles-Edouard LuytTarek SahnounMelchior GautierPauline VidalSonia BurrelMarc Pineton de ChambrunJuliette ChommelouxCyrielle DesnosJeremy ArzoineAnia NieszkowskaNicolas BréchotMatthieu SchmidtGuillaume HekimianDavid BoutolleauJérôme RobertAlain CombesJean ChastrePublished in: Annals of intensive care (2020)
Patients with severe Covid-19-associated ARDS requiring ECMO had a very high late-onset VAP rate. Inducible AmpC-cephalosporinase-producing Enterobacteriaceae and Pseudomonas aeruginosa frequently caused VAP, with multiple recurrences and difficulties eradicating the pathogen from the lung.
Keyphrases
- acute respiratory distress syndrome
- late onset
- sars cov
- pseudomonas aeruginosa
- early onset
- extracorporeal membrane oxygenation
- mechanical ventilation
- cystic fibrosis
- respiratory failure
- respiratory syndrome coronavirus
- biofilm formation
- acinetobacter baumannii
- coronavirus disease
- multidrug resistant
- candida albicans
- community acquired pneumonia
- klebsiella pneumoniae
- escherichia coli
- urinary tract infection